Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Almirall and Tyris Therapeutics enter into strategic partnership to develop next generation gene therapies

Friday, January 08, 2021

Almirall SA a global biopharmaceutical company based in Barcelona and Tyris Therapeutics a nextgeneration gene therapy company founded by Columbus Venture Partners have announced a strategic partnership today to tackle orphan dermatological condition...

Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy

Thursday, January 07, 2021

Dewpoint Therapeutics the biomolecular condensates company announced a new research collaboration with Pfizer for the development of potential therapeutics for the treatment of myotonic dystrophy type DM

Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms English

Thursday, January 07, 2021

Intravacc a world leader in translational research and development of vaccines and Cristal Therapeutics a technology leader in enabling safer and more effective therapeutics announced a strategic collaboration to develop novel vaccine programs agains...

Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine

Wednesday, January 06, 2021

Akston Biosciences which develops new classes of biologic therapeutics and LakePharma a leading USbased CRDMO serving the biotechnology community announced that they have established a strategic partnership LakePharma will manufacture commercial quan...

Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program

Wednesday, January 06, 2021

Morphic Therapeutic a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases today announced the expansion of its research and development collaboration with Janssen Pharmaceutic...

Angelini Pharma to acquire Arvelle Therapeutics, creating a leading European innovator in central nervous system and mental illness therapy

Tuesday, January 05, 2021

Angelini Pharma an international pharmaceutical company part of the private Italian Angelini Group and Arvelle Therapeutics a Switzerlandbased biopharmaceutical company specializing in the development of innovative therapies for patients with CNS di...

AGC Biologics confirms commercial expertise in gene and cell therapy as manufacturer of Libmeldy

Tuesday, January 05, 2021

AGC Biologics a prominent leading pharmaceutical contract development and manufacturing organization CDMO is the first manufacturer of Orchard Therapeutics Libmeldy product recently approved by the European Commission CE as a onetime therapy for val...

ImmunityBio Simulates SARS-CoV-2 Spike Protein Binding Using Molecular Dynamics

Monday, January 04, 2021

ImmunityBio a privatelyheld immunotherapy company today announced the results of a highly detailed computerbased molecular dynamics MD simulation conducted in collaboration with Microsoft Corporation that allowed visualization of the behavior of the...

Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804

Thursday, December 31, 2020

Incyte and Cellenkos Inc a privately held clinical stage biotech company announced a development collaboration to investigate the combination of ruxolitinib Jakafi and CK Cellenkos cryopreserved CXCR enriched allogeneic umbilical cord bloodderived Tr...

Wize Pharma and Cosmos Capital enter into Bid Implementation Agreement

Thursday, December 31, 2020

Wize Pharma Inc a clinicalstage biopharmaceutical company focused on the treatment of ophthalmic disorders and Cosmos Capital Limited a leading digital infrastructure provider based in Sydney Australia today announced that they have entered into a bi...